Brian Elsbernd - Net Worth and Insider Trading

Brian Elsbernd Net Worth

The estimated net worth of Brian Elsbernd is at least $3 Million dollars as of 2024-11-10. Brian Elsbernd is the Chief Compliance/Legal Officer of Catalyst Pharmaceuticals Inc and owns about 124,433 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $3 Million. Details can be seen in Brian Elsbernd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Elsbernd has not made any transactions after 2024-03-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Brian Elsbernd

To

Brian Elsbernd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Elsbernd owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .

Click here to see the complete history of Brian Elsbernd’s form 4 insider trades.

Insider Ownership Summary of Brian Elsbernd

Ticker Comapny Transaction Date Type of Owner
CPRX Catalyst Pharmaceuticals Inc 2024-03-27 Chief Compliance/Legal Officer

Brian Elsbernd Latest Holdings Summary

Brian Elsbernd currently owns a total of 1 stock. Brian Elsbernd owns 124,433 shares of Catalyst Pharmaceuticals Inc (CPRX) as of March 27, 2024, with a value of $3 Million.

Latest Holdings of Brian Elsbernd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPRX Catalyst Pharmaceuticals Inc 2024-03-27 124,433 23.93 2,977,682

Holding Weightings of Brian Elsbernd


Brian Elsbernd Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian Elsbernd has made a total of 3 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 25,000 shares on March 27, 2024, which brought Brian Elsbernd around $411,000.

Insider Trading History of Brian Elsbernd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian Elsbernd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian Elsbernd Ownership Network

Ownership Network List of Brian Elsbernd

No Data

Ownership Network Relation of Brian Elsbernd

Insider Network Chart

Brian Elsbernd Owned Company Details

What does Catalyst Pharmaceuticals Inc do?

Who are the key executives at Catalyst Pharmaceuticals Inc?

Brian Elsbernd is the Chief Compliance/Legal Officer of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .

Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary

Over the past 18 months, Brian Elsbernd made 1 insider transaction in Catalyst Pharmaceuticals Inc (CPRX) with a net sale of 25,000. Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .

In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.

Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Pharmaceuticals Inc Insider Transactions

No Available Data

Brian Elsbernd Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Elsbernd. You might contact Brian Elsbernd via mailing address: 355 Alhambra Circle, Coral Gables Fl 33134.